|

OKN4395 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Epkin1

Indications

  • Undifferentiated Pleomorphic Sarcoma (UPS)1
  • Dedifferentiated Liposarcoma1
  • Solitary Fibrous Tumors1
  • Myxofibrosarcoma (MFS)1
  • HNSCC1

Beverly Hills, California1 trial

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

Precision NextGen Oncology and Research Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.